Skip NavigationSkip to Content
NCI HeaderNational Cancer InstituteU.S. National Institutes of
CCR - For Our Staff| Home |

In the Press


Below are links to NCI press releases that highlight new advances in basic, clinical, and translational science at the Center for Cancer Research.

NCI Press Releases and News Notes - 2014

news item icon NIH study demonstrates that a new cancer immunotherapy method could be effective against a wide range of cancers

NCI Press Release
(Posted: 5/8/2014) - A new method for using immunotherapy to specifically attack tumor cells that have mutations unique to a patient's cancer has been developed by NCI scientists.

news item icon Study in mice shows that an aggressive type of breast cancer is linked to an inflammatory protein

NCI News Note
(Posted: 4/14/2014) - Aberrant expression of an inflammatory protein, nitric oxide synthase 2 (NOS2), may enhance the progression and metastasis of an aggressive and less common form of breast cancer, known as the estrogen receptor-negative type of disease.

news item icon NCI intramural research highlighted at 2014 AACR meeting

NCI Perspective Article
(Posted: 4/7/2014) - This year's American Association for Cancer Research meeting featured plenary talks by two NCI scientists, Steven Rosenberg, M.D., and Louis Staudt, M.D., Ph.D., that highlighted the challenges in developing varied and potentially synergistic treatments for aggressive forms of cancer. Each researcher has been focusing primarily on a particularly difficult to treat cancer (melanoma and lymphoma, respectively) for many decades, and their presentations highlight the diligence and tenacity needed to come to a better understanding of the cancer process and to find effective agents to target the diseases they study.

news item icon NIH scientists map genetic changes that drive tumors in a common pediatric soft-tissue cancer

NCI Press Release
(Posted: 1/23/2014) - Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes. The genetic alterations identified in this malignancy could be useful in developing targeted diagnostic tools and treatments for children with the disease.

Home | Contact Us | Policies | Accessibility | Viewing Files | Search | CCR - For Our Staff

A service of the National Cancer Institute

National Cancer InstituteNational Institutes of HealthHealth and Human ServicesUSA Gov - Official Web Portal